Search Results for "problematic PR releases"
It’s time for AAAS and EurekAlert! to crack down on misinformation in PR news releases
Whenever you see a news story that contains imbalanced and inaccurate information about health care, you’d be justified in wondering whether the content originated with a poor-quality PR news release. We’ve been demonstrating how these promotional documents can mislead readers about animal studies, phase 1 research, and minimally invasive surgery — to name just a few of the […]
Osteoporosis and vertebral compression fractures: Advocacy groups and medical device maker spin misleading message
In case you ever wondered, October 20th is World Osteoporosis Day. In preparation, two advocacy groups — the National Osteoporosis Foundation and the National Bone Health Alliance — have joined forces with Medtronic, the world’s largest medical device maker, to raise awareness about what they consider to be an “under-diagnosed” problem: vertebral compression fractures (VCF) from […]
Janssen highlights insignificant findings along with modest results in esketamine nasal spray trials
One of the studies (in elderly patients aged 65 and older with treatment-resistant depression) showed no statistical significance but the release says the drug had “meaningful effects” compared to placebo.
New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression
Animated map illustrates ‘wildfire spread’ of unregulated stem cell clinics in U.S.
A newly published animated map shows how an unregulated industry of stem cell clinics developed in less than a decade, growing from zero businesses in 2008 to nearly 600 in 2016. The map was created by UC Davis stem cell researcher Paul Knoepfler, PhD, and University of Minnesota bioethicist Leigh Turner, PhD, who first documented […]
AP’s write-up on a new continuous blood sugar monitor–where’s the proof that it works?
This brief piece announces FDA approval of a blood glucose monitor that does not require blood testing via finger pricks.
FDA OKs continuous blood sugar monitor without finger pricks
‘This is a major breakthrough:’ PR release on rapid MRI for dense breasts exemplifies why news stories need independent sources
One of the most important tenets of strong journalism is independent sourcing. The inclusion of outside sources is part of what separates real news from PR news releases. That’s why, when a news release with the boastful headline “New breast screening method to save thousands of women from cancer” hit my in-box, I quickly scanned […]
Health care PR in 2016: Who made the grade?
2016 was our first full year evaluating PR news releases that make claims about health care interventions. Ours is the only project that systematically evaluates these documents, which are designed to bring attention to something that the issuing organization thinks is newsworthy — often a new study about a test or treatment. Some — not […]
Reuters rehashes news release in story on deep-sea laser treatment for prostate cancer
News outlets that run PR pieces and call them news stories undermine the credibility of health journalism and erode the ability of real health reporting to advance public dialogue.
Laser therapy with deep-sea drug kills prostate cancer in trial
FDA release on Intrarosa approval omits important conflict of interest
The research on the trial of a drug for alleviating pain in postmenopausal women during sex was conducted and written by the manufacturer. That’s not mentioned in the release.
FDA approves Intrarosa for postmenopausal women experiencing pain during sex
Journalists need to prune the overgrowth in the jungle of supplement news
Enter any chain pharmacy these days and you’ll likely find an entire aisle devoted to vitamins and supplements. Which isn’t surprising, given Americans spend roughly $30 billion on them annually. Problem is, as noted by Jane Brody in a recent New York Times article, there’s mounting evidence that supplements provide essentially no benefit to most […]1
“Skyrocketing” prostate cancer? Journos, cool your jets
[Editor’s note: This post has been updated; see the addenda at the bottom.] Headlines from multiple news outlets today report that metastatic prostate cancer is “soaring,” “surging” and “skyrocketing.” The alarming headlines are based on a study that found a 72% increase in metastatic disease cases (cancers that have spread beyond the prostate) between 2004 […]12
More BMJ overstatement about an observational study — this time it’s antidepressants and violent crime
The following is a guest blog post by Dr. Susan Molchan, one of our independent expert editorial contributors. Last week PLOS Medicine published the results of a large observational study that showed an association between the selective serotonin reuptake inhibitor (SSRI) class of anti-depressants (e.g. Prozac and Paxil) and violent crime in young people. As a […]
Magic mushrooms for mental health? Shaky basis for story’s proposed “‘paradigm shift”
This story raises intriguing questions, but doesn’t provide enough detail to help readers understand what the answers might be.
Psychedelics Promise a ‘Paradigm Shift’ in Treating Mental Illness
Why ‘approved’ medical devices in the U.S. may not be safe or effective
“Medtronic receives FDA clearance for two heart devices” “FDA approves device to help curb cluster headaches” MRI approved for young infants in intensive care Headlines like these instill consumer confidence that medical devices are safe and effective. After all, they have the FDA’s stamp of approval, right? The reality is, the FDA seldom requires rigorous […]
Podcast: Our team reflects on what we’ve learned
After over 12 years of scrutinizing medical news to help improve the public dialogue on health care, HealthNewsReview.org closes up shop at the end of 2018.
In this podcast, the seven members of the staff take a look back and share what they’ve learned from the experience.